DXCM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 27 of 35 cases where DXCM's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 77%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where DXCM's RSI Indicator exited the oversold zone, 25 of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Moving Average Convergence Divergence (MACD) for DXCM just turned positive on November 12, 2026. Looking at past instances where DXCM's MACD turned positive, the stock continued to rise in 31 of 45 cases over the following month. The odds of a continued upward trend are 69%.
Following a +1.11% 3-day Advance, the price is estimated to grow further. Considering data from situations where DXCM advanced for three days, in 200 of 295 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DXCM as a result. In 65 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 73%.
DXCM moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DXCM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
The Aroon Indicator for DXCM entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 27 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. DXCM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 54 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 83 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.431) is normal, around the industry mean (4.142). P/E Ratio (30.779) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (1.332) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (6.988) is also within normal values, averaging (40.124).
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DXCM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
MID's Aroon Indicator triggered a bullish signal on November 12, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 286 similar instances where the Aroon Indicator showed a similar pattern. In 244 of the 286 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 85%.
The Moving Average Convergence Divergence Histogram (MACD) for MID turned negative on October 22, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 33 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.
DXCM | ||
|---|---|---|
OUTLOOK RATING 1..100 | 19 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 83 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 27 | |
PRICE GROWTH RATING 1..100 | 47 | |
P/E GROWTH RATING 1..100 | 54 | |
SEASONALITY SCORE 1..100 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| DXCM | MID | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 69% | N/A |
| Stochastic ODDS (%) | 1 day ago 73% | N/A |
| Momentum ODDS (%) | 1 day ago 73% | N/A |
| MACD ODDS (%) | 1 day ago 69% | 1 day ago 77% |
| TrendWeek ODDS (%) | 1 day ago 66% | 1 day ago 82% |
| TrendMonth ODDS (%) | 1 day ago 74% | 1 day ago 81% |
| Advances ODDS (%) | 1 day ago 68% | N/A |
| Declines ODDS (%) | 13 days ago 74% | N/A |
| BollingerBands ODDS (%) | 1 day ago 77% | N/A |
| Aroon ODDS (%) | 1 day ago 61% | 1 day ago 85% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DXCM’s FA Score shows that 1 FA rating(s) are green while .
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DXCM’s TA Score shows that 5 TA indicator(s) are bullish.
DXCM (@Medical/Nursing Services) experienced а +2.65% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -8.60%. For the same industry, the average monthly price growth was -8.87%, and the average quarterly price growth was -14.08%.
DXCM is expected to report earnings on Feb 11, 2027.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor indicates that over the last year, DXCM has been loosely correlated with ISRG. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DXCM jumps, then ISRG could also see price increases.
| Ticker / NAME | Correlation To DXCM | 1D Price Change % | ||
|---|---|---|---|---|
| DXCM | 100% | +0.59% | ||
| ISRG - DXCM | 46% Loosely correlated | -2.23% | ||
| ALGN - DXCM | 44% Loosely correlated | +0.31% | ||
| LIVN - DXCM | 42% Loosely correlated | +2.85% | ||
| PODD - DXCM | 41% Loosely correlated | -3.69% | ||
| NVST - DXCM | 40% Loosely correlated | +0.21% | ||
More | ||||
A.I.dvisor tells us that MID and XYZ have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MID and XYZ's prices will move in lockstep.
| Ticker / NAME | Correlation To MID | 1D Price Change % | ||
|---|---|---|---|---|
| MID | 100% | N/A | ||
| XYZ - MID | 22% Poorly correlated | -0.38% | ||
| CRWV - MID | 15% Poorly correlated | -4.13% | ||
| VST - MID | 14% Poorly correlated | -1.23% | ||
| DXCM - MID | 13% Poorly correlated | +0.59% | ||
| TPL - MID | 12% Poorly correlated | -0.67% | ||
More | ||||